CD27 costimulation is not critical for the development of asthma and respiratory tolerance in a murine model

Immunology Letters

Volumn 133, Issue 1, 2010, Pages 19-27

  Behrendt, Ann Kathrin ^a   Hansen, Gesine ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Allergic asthma; CD27; Costimulation; Murine asthma model; Respiratory tolerance

Indexed keywords

CD27 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 5; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; EOSINOPHIL; FEMALE; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; IN VITRO STUDY; MOUSE; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; SPLEEN CELL; SUPERNATANT; TH2 CELL; WILD TYPE;

ANIMALS; ANTIGENS, CD27; ASTHMA; BRONCHIAL HYPERREACTIVITY; CELLS, CULTURED; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE TOLERANCE; IMMUNIZATION; IMMUNOGLOBULIN E; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; PULMONARY EOSINOPHILIA; T-LYMPHOCYTES;

EID: 77955851802     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2010.06.004     Document Type: Article

References (45)

1. Lloyd C.M., Hawrylowicz C.M. Regulatory T cells in asthma. Immunity 2009, 31:438-449.
2. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998, 351:1225-1232.
3. Braman S.S. The global burden of asthma. Chest 2006, 130:4S-12S.
4. Nurieva R.I., Liu X., Dong C. Yin-Yang of costimulation: crucial controls of immune tolerance and function. Immunol Rev 2009, 229:88-100.
5. Deurloo D.T., van Oosterhout A.J. Role of T cell co-stimulation in murine models of allergic asthma. Clin Exp Allergy 2004, 34:17-25.
6. Sharpe A.H. Mechanisms of costimulation. Immunol Rev 2009, 229:5-11.
7. Camerini D., Walz G., Loenen W.A., Borst J., Seed B. The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J Immunol 1991, 147:3165-3169.
8. Hintzen R.Q., Lens S.M., Lammers K., Kuiper H., Beckmann M.P., van Lier R.A. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. J Immunol 1995, 154:2612-2623.
9. Borst J., Hendriks J., Xiao Y. CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol 2005, 17:275-281.
10. Croft M. The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 2009, 9:271-285.
11. Bowman M.R., Crimmins M.A., Yetz-Aldape J., Kriz R., Kelleher K., Herrmann S. The cloning of CD70 and its identification as the ligand for CD27. J Immunol 1994, 152:1756-1761.
12. Agematsu K., Kobata T., Sugita K., Hirose T., Schlossman S.F., Morimoto C. Direct cellular communications between CD45R0 and CD45RA T cell subsets via CD27/CD70. J Immunol 1995, 154:3627-3635.
13. Jacquot S. CD27/CD70 interactions regulate T dependent B cell differentiation. Immunol Res 2000, 21:23-30.
14. Nagumo H., Agematsu K., Shinozaki K., Hokibara S., Ito S., Takamoto M., et al. CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells. J Immunol 1998, 161:6496-6502.
15. Sumi T., Ishida W., Ojima A., Kajisako M., Sakanishi T., Yagita H., et al. CD27 and CD70 do not play a critical role in the development of experimental allergic conjunctivitis in mice. Immunol Lett 2008, 119:91-96.
16. Polte T., Fuchs L., Behrendt A.K., Hansen G. Different role of CD30 in the development of acute and chronic airway inflammation in a murine asthma model. Eur J Immunol 2009, 39:1736-1742.
17. Polte T., Behrendt A.K., Hansen G. Direct evidence for a critical role of CD30 in the development of allergic asthma. J Allergy Clin Immunol 2006, 118:942-948.
18. Salek-Ardakani S., Song J., Halteman B.S., Jember A.G., Akiba H., Yagita H., et al. OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation. J Exp Med 2003, 198:315-324.
19. Jember A.G., Zuberi R., Liu F.T., Croft M. Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40. J Exp Med 2001, 193:387-392.
20. Polte T., Jagemann A., Foell J., Mittler R.S., Hansen G. CD137 ligand prevents the development of T-helper type 2 cell-mediated allergic asthma by interferon-gamma-producing CD8+ T cells. Clin Exp Allergy 2007, 37:1374-1385.
21. Polte T., Foell J., Werner C., Hoymann H.G., Braun A., Burdach S., et al. CD137-mediated immunotherapy for allergic asthma. J Clin Invest 2006, 116:1025-1036.
22. Cho Y.S., Kwon B., Lee T.H., Kim T.B., Moon K.A., La S., et al. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model. Clin Exp Allergy 2006, 36:377-385.
23. Lombardi V., Singh A.K., Akbari O. The role of costimulatory molecules in allergic disease and asthma. Int Arch Allergy Immunol 2009, 151:179-189.
24. Hansen G., Berry G., DeKruyff R.H., Umetsu D.T. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999, 103:175-183.
25. Hansen G., McIntire J.J., Yeung V.P., Berry G., Thorbecke G.J., Chen L., et al. CD4(+) T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation. J Clin Invest 2000, 105:61-70.
26. Hansen G., Jin S., Umetsu D.T., Conti M. Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D. Proc Natl Acad Sci U S A 2000, 97:6751-6756.
27. Polte T., Hennig C., Hansen G. Allergy prevention starts before conception: maternofetal transfer of tolerance protects against the development of asthma. J Allergy Clin Immunol 2008, 122:1022-1030. e1025.
28. Polte T., Hansen G. Maternal tolerance achieved during pregnancy is transferred to the offspring via breast milk and persistently protects the offspring from allergic asthma. Clin Exp Allergy 2008, 38:1950-1958.
29. Fukushima A., Yamaguchi T., Ishida W., Fukata K., Mittler R.S., Yagita H., et al. Engagement of 4-1BB inhibits the development of experimental allergic conjunctivitis in mice. J Immunol 2005, 175:4897-4903.
30. Fukushima A., Yamaguchi T., Ishida W., Fukata K., Yagita H., Ueno H. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40. Invest Ophthalmol Vis Sci 2006, 47:657-663.
31. Bengtsson A. The role of CD30 in atopic disease. Allergy 2001, 56:593-603.
32. Heshmat N.M., El-Hadidi E.S. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age. Pediatr Allergy Immunol 2006, 17:297-303.
33. Oflazoglu E., Simpson E.L., Takiguchi R., Grewal I.S., Hanifin J.M., Gerber H.P. CD30 expression on CD1a+ and CD8+ cells in atopic dermatitis and correlation with disease severity. Eur J Dermatol 2008, 18:41-49.
34. Hoshino A., Tanaka Y., Akiba H., Asakura Y., Mita Y., Sakurai T., et al. Critical role for OX40 ligand in the development of pathogenic Th2 cells in a murine model of asthma. Eur J Immunol 2003, 33:861-869.
35. So T., Lee S.W., Croft M. Immune regulation and control of regulatory T cells by OX40 and 4-1BB. Cytokine Growth Factor Rev 2008, 19:253-262.
36. Duan W., So T., Croft M. Antagonism of airway tolerance by endotoxin/lipopolysaccharide through promoting OX40L and suppressing antigen-specific Foxp3+ T regulatory cells. J Immunol 2008, 181:8650-8659.
37. Bansal-Pakala P., Jember A.G., Croft M. Signaling through OX40 (CD134) breaks peripheral T-cell tolerance. Nat Med 2001, 7:907-912.
38. Hendriks J., Gravestein L.A., Tesselaar K., van Lier R.A., Schumacher T.N., Borst J. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol 2000, 1:433-440.
39. Hendriks J., Xiao Y., Borst J. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J Exp Med 2003, 198:1369-1380.
40. Arens R., Schepers K., Nolte M.A., van Oosterwijk M.F., van Lier R.A., Schumacher T.N., et al. Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation. J Exp Med 2004, 199:1595-1605.
41. Rowley T.F., Al-Shamkhani A. Stimulation by soluble CD70 promotes strong primary and secondary CD8+ cytotoxic T cell responses in vivo. J Immunol 2004, 172:6039-6046.
42. Yamada A., Salama A.D., Sho M., Najafian N., Ito T., Forman J.P., et al. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo. J Immunol 2005, 174:1357-1364.
43. Nakajima A., Oshima H., Nohara C., Morimoto S., Yoshino S., Kobata T., et al. Involvement of CD70-CD27 interactions in the induction of experimental autoimmune encephalomyelitis. J Neuroimmunol 2000, 109:188-196.
44. Oflazoglu E., Boursalian T.E., Zeng W., Edwards A.C., Duniho S., McEarchern J.A., et al. Blocking of CD27-CD70 pathway by anti-CD70 antibody ameliorates joint disease in murine collagen-induced arthritis. J Immunol 2009, 183:3770-3777.
45. Manocha M., Rietdijk S., Laouar A., Liao G., Bhan A., Borst J., et al. Blocking CD27-CD70 costimulatory pathway suppresses experimental colitis. J Immunol 2009, 183:270-276.